Source: Cancer Research. Conference titles: Annual Meeting of the American Association for Cancer Research. Unidade: FMVZ
Subjects: MELATONINA, NEOPLASIAS MAMÁRIAS, TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE PÓSITRON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTA, André de Lima et al. Melatonin action in xenograft model of breast cancer, comparing radiopharmaceuticals in the detection of intratumor heterogeneity by PET/CT confirmed by immunohistochemical markers. Cancer Research. Philadelphia: American Association for Cancer Research. Disponível em: https://doi.org/10.1158/1538-7445.AM2016-2408. Acesso em: 29 jun. 2024. , 2016APA
Mota, A. de L., Jardim-Perassi, B. V., Borin, T. F., Sonehara, N. M., Pozzo, L., Bernardes, E. S., et al. (2016). Melatonin action in xenograft model of breast cancer, comparing radiopharmaceuticals in the detection of intratumor heterogeneity by PET/CT confirmed by immunohistochemical markers. Cancer Research. Philadelphia: American Association for Cancer Research. doi:10.1158/1538-7445.AM2016-2408NLM
Mota A de L, Jardim-Perassi BV, Borin TF, Sonehara NM, Pozzo L, Bernardes ES, Cogliati B, Zuccari DAP de C. Melatonin action in xenograft model of breast cancer, comparing radiopharmaceuticals in the detection of intratumor heterogeneity by PET/CT confirmed by immunohistochemical markers [Internet]. Cancer Research. 2016 ; 76 1 .[citado 2024 jun. 29 ] Available from: https://doi.org/10.1158/1538-7445.AM2016-2408Vancouver
Mota A de L, Jardim-Perassi BV, Borin TF, Sonehara NM, Pozzo L, Bernardes ES, Cogliati B, Zuccari DAP de C. Melatonin action in xenograft model of breast cancer, comparing radiopharmaceuticals in the detection of intratumor heterogeneity by PET/CT confirmed by immunohistochemical markers [Internet]. Cancer Research. 2016 ; 76 1 .[citado 2024 jun. 29 ] Available from: https://doi.org/10.1158/1538-7445.AM2016-2408
